Antiviral resistance against viral mutation: praxis and policy for SARS-CoV-2

DOI10.1515/CMB-2020-0119zbMATH Open1472.92139OpenAlexW3177792097MaRDI QIDQ2236688FDOQ2236688

Robert Penner

Publication date: 26 October 2021

Published in: Computational and Mathematical Biophysics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1515/cmb-2020-0119

Recommendations

• Learning the language of viral evolution and escape
• Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
• A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution
• SARS-CoV-2 becoming more infectious as revealed by algebraic topology and deep learning
• The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19

zbMATH Keywords

virologymRNA technologystructural biologyvaccinologyvirus-vector

Mathematics Subject Classification ID

Medical epidemiology (92C60) Biochemistry, molecular biology (92C40)

This page was built for publication: Antiviral resistance against viral mutation: praxis and policy for SARS-CoV-2

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2236688)